(CENX) Century Aluminum - Overview
Stock: Aluminum, Bauxite, Alumina, Anodes
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 70.8% |
| Relative Tail Risk | -11.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.75 |
| Alpha | 159.67 |
| Character TTM | |
|---|---|
| Beta | 1.834 |
| Beta Downside | 1.805 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.12% |
| CAGR/Max DD | 1.33 |
Description: CENX Century Aluminum January 14, 2026
Century Aluminum Company (NASDAQ:CENX) manufactures and markets primary aluminum products-including standard-grade and value-added alloys-in the United States and Iceland, while also operating a carbon anode plant in the Netherlands and maintaining bauxite mining and alumina-refining assets in Jamaica. Founded in 1995 and headquartered in Chicago, the firm is classified under the GICS Aluminum sub-industry.
Key recent metrics (FY 2023) show revenue of roughly $1.2 billion, an adjusted EBITDA margin near 12 %, and an operating capacity of about 720 kt of primary aluminum, with utilization hovering around 85 % despite elevated electricity costs. The company’s earnings are highly sensitive to global aluminum spot prices (currently ~ $2,300/ton) and to energy price volatility, while long-term demand is driven by automotive lightweighting, construction activity, and the broader shift toward renewable-energy infrastructure-all of which have been accelerating in 2024.
For a deeper dive into CENX’s valuation metrics, the ValueRay platform offers a concise, data-rich overview.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 85.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -0.78 > 1.0 |
| NWC/Revenue: 16.95% < 20% (prev 15.92%; Δ 1.03% < -1%) |
| CFO/TA 0.02 > 3% & CFO 40.8m > Net Income 85.2m |
| Net Debt (467.1m) to EBITDA (194.4m): 2.40 < 3 |
| Current Ratio: 1.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.2m) vs 12m ago 0.81% < -2% |
| Gross Margin: 9.52% > 18% (prev 0.08%; Δ 944.5% > 0.5%) |
| Asset Turnover: 125.3% > 50% (prev 110.8%; Δ 14.48% > 0%) |
| Interest Coverage Ratio: 2.48 > 6 (EBITDA TTM 194.4m / Interest Expense TTM 46.7m) |
Altman Z'' -2.04
| A: 0.20 (Total Current Assets 1.03b - Total Current Liabilities 599.1m) / Total Assets 2.13b |
| B: -0.76 (Retained Earnings -1.63b / Total Assets 2.13b) |
| C: 0.06 (EBIT TTM 115.8m / Avg Total Assets 2.02b) |
| D: -1.20 (Book Value of Equity -1.72b / Total Liabilities 1.44b) |
| Altman-Z'' Score: -2.04 = D |
Beneish M -3.45
| DSRI: 0.54 (Receivables 132.6m/205.7m, Revenue 2.53b/2.10b) |
| GMI: 0.79 (GM 9.52% / 7.52%) |
| AQI: 0.96 (AQ_t 0.06 / AQ_t-1 0.07) |
| SGI: 1.20 (Revenue 2.53b / 2.10b) |
| TATA: 0.02 (NI 85.2m - CFO 40.8m) / TA 2.13b) |
| Beneish M-Score: -3.45 (Cap -4..+1) = AA |
What is the price of CENX shares?
Over the past week, the price has changed by +15.60%, over one month by +24.08%, over three months by +80.81% and over the past year by +179.47%.
Is CENX a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CENX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 59 | 12.6% |
| Analysts Target Price | 59 | 12.6% |
| ValueRay Target Price | 70.5 | 34.6% |
CENX Fundamental Data Overview February 07, 2026
P/S = 1.937
P/B = 5.899
P/EG = -1.36
Revenue TTM = 2.53b USD
EBIT TTM = 115.8m USD
EBITDA TTM = 194.4m USD
Long Term Debt = 479.2m USD (from longTermDebt, last quarter)
Short Term Debt = 139.3m USD (from shortTermDebt, last quarter)
Debt = 618.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 467.1m USD (from netDebt column, last quarter)
Enterprise Value = 5.36b USD (4.89b + Debt 618.5m - CCE 151.4m)
Interest Coverage Ratio = 2.48 (Ebit TTM 115.8m / Interest Expense TTM 46.7m)
EV/FCF = -142.9x (Enterprise Value 5.36b / FCF TTM -37.5m)
FCF Yield = -0.70% (FCF TTM -37.5m / Enterprise Value 5.36b)
FCF Margin = -1.49% (FCF TTM -37.5m / Revenue TTM 2.53b)
Net Margin = 3.37% (Net Income TTM 85.2m / Revenue TTM 2.53b)
Gross Margin = 9.52% ((Revenue TTM 2.53b - Cost of Revenue TTM 2.28b) / Revenue TTM)
Gross Margin QoQ = 12.23% (prev 5.76%)
Tobins Q-Ratio = 2.51 (Enterprise Value 5.36b / Total Assets 2.13b)
Interest Expense / Debt = 1.86% (Interest Expense 11.5m / Debt 618.5m)
Taxrate = 9.40% (1.10m / 11.7m)
NOPAT = 104.9m (EBIT 115.8m * (1 - 9.40%))
Current Ratio = 1.71 (Total Current Assets 1.03b / Total Current Liabilities 599.1m)
Debt / Equity = 0.83 (Debt 618.5m / totalStockholderEquity, last quarter 741.8m)
Debt / EBITDA = 2.40 (Net Debt 467.1m / EBITDA 194.4m)
Debt / FCF = -12.46 (negative FCF - burning cash) (Net Debt 467.1m / FCF TTM -37.5m)
Total Stockholder Equity = 721.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.23% (Net Income 85.2m / Total Assets 2.13b)
RoE = 11.81% (Net Income TTM 85.2m / Total Stockholder Equity 721.7m)
RoCE = 9.64% (EBIT 115.8m / Capital Employed (Equity 721.7m + L.T.Debt 479.2m))
RoIC = 8.61% (NOPAT 104.9m / Invested Capital 1.22b)
WACC = 11.44% (E(4.89b)/V(5.51b) * Re(12.67%) + D(618.5m)/V(5.51b) * Rd(1.86%) * (1-Tc(0.09)))
Discount Rate = 12.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.00%
Fair Price DCF = unknown (Cash Flow -37.5m)
EPS Correlation: 22.64 | EPS CAGR: -22.43% | SUE: -4.0 | # QB: 0
Revenue Correlation: -32.06 | Revenue CAGR: -1.11% | SUE: 0.06 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.73 | Chg30d=+0.720 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=5.96 | Chg30d=+0.095 | Revisions Net=+1 | Growth EPS=+142.5% | Growth Revenue=+13.4%